| HNF4A Protein | |
|---|---|
| Protein Name | HNF4A Protein |
| Gene Symbol | HNF4A |
| UniProt ID | P41235 |
| PDB Structures | 5WS3, 5WSA |
| Molecular Weight | 52 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | Nuclear Receptor Family |
HNF4A is a protein involved in cellular signaling and transcriptional regulation.[1] This protein plays important roles in regulating gene expression and cellular signaling.[2] In the context of neurodegenerative diseases, HNF4A is implicated in Alzheimer's disease, Parkinson's disease, and other disorders through various mechanisms.[3]
HNF4A is a ligand-activated transcription factor with a typical nuclear receptor structure: an N-terminal activation domain, a DNA-binding domain (DBD) with two zinc fingers, a hinge region, and a ligand-binding domain (LBD). The LBD contains a hydrophobic ligand-binding pocket. HNF4A binds DNA as a homodimer to direct repeat 1 (DR1) response elements. The protein has multiple isoforms generated by alternative promoter usage and splicing.
HNF4A is a nuclear receptor transcription factor that regulates genes involved in metabolism, development, and cell differentiation. It plays crucial roles in pancreatic beta-cell function, hepatic gene expression, and lipid metabolism. HNF4A regulates genes involved in glucose transport, glycolysis, insulin secretion, and lipid metabolism. It is essential for normal pancreatic development and function. HNF4A also has roles in kidney and intestinal function.
HNF4A is implicated in neurodegenerative diseases through its metabolic functions. In Alzheimer's disease, HNF4A polymorphisms affect AD risk and expression is altered in AD brain. HNF4A regulates genes involved in amyloid-beta metabolism and clearance. In Parkinson's disease, HNF4A influences mitochondrial function and oxidative stress response. HNF4A also plays roles in neuroinflammation. The protein represents a link between metabolic dysfunction and neurodegeneration.
HNF4A modulators are being explored for metabolic diseases. In neurodegeneration, enhancing HNF4A activity may have beneficial effects through improved metabolic function. However, HNF4A modulators need to be carefully targeted to avoid systemic metabolic effects. Gene therapy approaches to restore HNF4A function are being investigated. The protein represents a potential therapeutic target for neurodegenerative diseases with metabolic components.